高剂量静脉铁剂在孕产妇贫血治疗中的应用

滕忻园; 王利权

doi:10.19538/j.fk2025100108

PDF(958 KB)

中国实用妇科与产科杂志 ›› 2025, Vol. 41 ›› Issue (10) : 986-989. DOI: 10.19538/j.fk2025100108

专题笔谈

高剂量静脉铁剂在孕产妇贫血治疗中的应用

滕忻园 ,
王利权

作者信息 +

Application of high-dose intravenous iron in the treatment of anemia in pregnant and postpartum women

Author information +

文章历史 +

摘要

孕期及产褥期贫血是全球性的公共卫生问题，与不良产科结局显著相关，铁缺乏是其发生的主要原因。目前，新型高剂量静脉铁剂，即15~30min内可单次输注≥1000 mg的静脉铁剂已在国内上市，但妇产科医生对其在孕产妇中应用的有效性及安全性认识不足。因此，文章就高剂量静脉铁剂在孕产妇的应用进行了讨论。

Abstract

Anemia during pregnancy and the postpartum period is a global public health issue，significantly associated with adverse obstetric outcomes，and iron deficiency （ID） is its primary cause. Currently，novel high-dose intravenous iron formulations，which allow single-dose infusion of ≥1000 mg within 15-30 minutes，have been approved for clinical use in China. However，obstetricians and gynecologists lack sufficient understanding of their efficacy and safety in pregnant and postpartum women. This article discusses the application of high-dose intravenous iron in pregnant and postpartum women.

导出引用

滕忻园, 王利权. 高剂量静脉铁剂在孕产妇贫血治疗中的应用[J]. 中国实用妇科与产科杂志. 2025, 41(10): 986-989 https://doi.org/10.19538/j.fk2025100108

TENG Xin-yuan, WANG Li-quan. Application of high-dose intravenous iron in the treatment of anemia in pregnant and postpartum women[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2025, 41(10): 986-989 https://doi.org/10.19538/j.fk2025100108

中图分类号： R714.147

参考文献

列表( 原文顺序 | 文献年度倒序 | 文中引用次数倒序 ) 可视化分析

[1]	王永生, 李小芹. 儿童生长迟缓营养干预[J]. 中国实用儿科杂志, 2024, 39(4):273-277. DOI:10.19538/j.ek2024040607. 本文引用 [1]

[2]	Van Doren L, Steinheiser M, Boykin K, et al. Expert consensus guidelines:Intravenous iron uses,formulations,administration,and management of reactions[J]. Am J Hematol, 2024, 99(7):1338-1348. DOI: 10.1002/ajh.27220. 本文引用 [5]

[3]	方灵漪, 王亚娟, 李洁, 等. 异麦芽糖酐铁应用于产后缺铁性贫血的前瞻性、随机、单中心临床试验的效果评估[J]. 实用妇产科杂志, 2025, 41(1): 54-59. DOI:1003-6946(2025)01-0054-06. 本文引用 [3]

[4]	孙文韬, 庄铃香, 马爱霞, 等. 羧基麦芽糖铁治疗中国缺铁性贫血成人患者的成本-效果分析[J]. 中国药房,2023, 34(22): 2750-2755. DOI: 1003-6946(2025)01-0054-06. 本文引用 [2]

[5]	中国药理学会药源性疾病学专业委员会, 广东省药学会. 静脉铁剂的临床应用和药学监护专家共识(2024)[J]. 药物不良反应杂志, 2025, 27(3):129-141. DOI:10.6039/j.issn.1001-0408.2023.22.11. 本文引用 [7]

[6]	中华医学会血液学分会红细胞疾病(贫血)学组. 静脉铁剂应用中国专家共识(2019年版)[J]. 中华血液学杂志, 2019, 40(5):358-362. DOI: 10.3760/cma.j.issn.0253-2727.2019.05.002. 本文引用 [1]

[7]	Hansen R, Sommer VM, Pinborg A, et al. Intravenous ferric derisomaltose versus oral iron for persistent iron deficient pregnant women:a randomised controlled trial[J]. Arch Gynecol Obstet, 2023, 308(4):1165-1173. DOI: 10.1007/s00404-022-06768-x. 本文引用 [1]

[8]	Sugimura M, Ohtani Y, Tamai S, et al. Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage:Results of a single-arm,open-label,phase 3 study in Japan[J]. J Obstet Gynaecol Res, 2023, 49(3):946-955. DOI:10.1016/S0140-6736(23)00278-7. 本文引用 [1]

[9]	Holm C, Thomsen LL, Norgaard A, et al. Single-dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage:a randomized controlled trial[J]. Vox Sang, 2017, 112(3):219-228. DOI:10.1111/vox.12477. 本文引用 [1]

[10]	Bombač Tavčar L, Hrobat H, Gornik L, et al. Maternal fatigue after postpartum anemia treatment with intravenous ferric carboxymaltose vs. intravenous ferric derisomaltose vs. oral ferrous sulphate: a randomized controlled trial[J]. J Clin Med, 2024, 13(3):758. DOI:10.3390/jcm13030758. 本文引用 [1]

[11]	Jose A, Mahey R, Sharma JB, et al. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron-deficiency anemia in pregnancy- randomised controlled trial[J]. BMC Pregnancy Childbirth, 2019, 19(1):54. DOI:10.1186/s12884-019-2200-3. 本文引用 [1]

[12]	Srimathi G, Revathy R, Bagepally BS, et al. Clinical effectiveness of ferric carboxymaltose (iv) versus iron sucrose (iv) in treatment of iron-deficiency anaemia in pregnancy:A systematic review and meta-analysis[J]. Indian J Med Res, 2024, 159(1):62-70. DOI:10.4103/ijmr.ijmr. 本文引用 [1]

[13]	Breymann C, Milman N, Mezzacasa A, et al. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron-deficiency anemia: an international,open-label,randomized controlled trial (FER-ASAP)[J]. J Perinat Med, 2017, 45(4):443-453. DOI:10.1515/jpm-2016-0050. 本文引用 [1]

[14]

Vanobberghen

, Lweno

, Kuemmerle

, et al. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron-deficiency anaemia in women after childbirth in Tanzania: a parallel-group,open-label,randomised controlled phase 3 trial[J]. Lancet Glob Health, 2021, 9(2):e189-e198. DOI:10.1016/S2214-109X(20)30448-4.

本文引用 [2]

[15]	Fraser A, Cairnes V, Mikkelsen E, et al. Understanding and managing infusion reactions and hypophosphataemia with intravenous iron-a nurses' consensus paper[J]. Nurs Open, 2025, 12(4):e70191. DOI:10.1002/nop2.70191. 本文引用 [2]

[16]	Achebe M, DeLoughery TG. Clinical data for intravenous iron-debunking the hype around hypersensitivity[J]. Transfusion, 2020, 60(6):1154-1159. DOI: 10.1111/trf.15837. 本文引用 [4]

[17]

Kennedy

, Achebe

, Biggar

, et al. A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose[J]. Int J Clin Pharm, 2023, 45(3):604-612. DOI:10.1007/s11096-023-01548-2.

本文引用 [1]

[18]	Huang LL, Lee D, Troster SM, et al. A controlled study of the effects of ferric carboxymaltose on bone and haematinic biomarkers in chronic kidney disease and pregnancy[J]. Nephrol Dial Transplant, 2018, 33(9):1628-1635. DOI:10.1093/ndt/gfx310. 本文引用 [1]

[19]	Auerbach M, DeLoughery TG, Tirnauer JS. Iron deficiency in adults: a review[J]. JAMA, 2025, 333(20):1813-1823. DOI:10.1001/jama.2025.0452. 本文引用 [1]

[20]	Wolf M, Rubin J, Achebe M, et al. Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia:two randomized clinical trials[J]. JAMA, 2020, 323(5):432-443. DOI: 10.1001/jama.2019.22450. 本文引用 [1]

[21]	赵岩, 刘彩霞, 魏军, 等. 双胎妊娠期缺铁性贫血诊治及保健指南(2023年版)[J]. 中国实用妇科与产科杂志, 2023, 39(4):419-430.DOI:10.19538/j.fk2023040110. 本文引用 [1]

[22]	李莉艳, 王志坚. 妊娠期地中海贫血的管理与遗传咨询[J]. 中国实用妇科与产科杂志, 2022, 38(12):1159-1163.DOI:10.19538/j.fk2022120103. 本文引用 [1]

[23]	赵艳, 吴捷. 儿童胆汁淤积性肝病的营养管理[J]. 中国实用儿科杂志, 2024, 39(4):259-263. DOI:10.19538/j.ek2024040604. 本文引用 [1]